ISHL12 - Emerging Concepts in Early Stages
  
 Dear colleagues,  
  
 The 12ᵗʰ International Symposium on Hodgkin Lymphoma (ISHL12) will take place in Cologne, Germany, between October 24 and 26, 2020.  
  
 ISHL12 will cover the whole spectrum of research related to Hodgkin Lymphoma (HL).  
  
  
 

Emerging Concepts
in Early Stages

 
  
 During this three-day conference, an additional focus will be patients with early stage disease. Balancing toxicity and treatment intensity is an ongoing quest in these patients.  
  
 Recent phase III trials reported a significant loss of tumor control with omission of radiotherapy in PET-negative early-stage favorable patients (RAPID, H10F, HD16). In patients with early-stage unfavorable disease, intensification of systemic therapy in interim PET-positive patients results in improved outcomes (H10U), while data regarding consolidative RT are more heterogeneous (RAPID, H10U).  
  
 The large randomized GHSG HD17 trial is nearing its final analysis and results will shed light on the possibility to omit RT after intensified systemic therapy. In addition, current trials are investigating systemic therapies incorporating novel agents such as brentuximab vedotin or anti-PD1 antibodies and results including correlative studies are eagerly awaited.  
  
 Taken together, these ongoing efforts are likely to shape the future therapy of early-stage Hodgkin Lymphoma which will be discussed at ISHL12 in detail.  
  
  
 

Stay informed

 
  
 Our homepage provides you with more information on ISHL12. Alternatively, you can contact our organizational team at info@hodgkinsymposium.org.  
  
  
 With best regards,  
  
 
Andreas Engert, MD,
Symposium and GHSG Chairman
Sven Borchmann, MD,
Symposium Secretary
Paul J. Bröckelmann, MD,
Symposium Secretary
Dennis A. Eichenauer, MD,
Symposium Secretary
 
  
 Please do not reply directly to this message. If you would like more information on the 12ᵗʰ International Symposium on Hogkin Lymphoma, or have additional questions please contact Gabriele Hanke (info@hodgkinsymposium.org).  
 Please add enews@hodgkinsymposium.org to your address book to prevent spam filters from blocking these E-Mails.  
 12ᵗʰ International Symposium on Hodgkin Lymphoma
Prof. Dr. med. Andreas Engert
Professor for Internal Medicine, Hematology & Oncology
German Hodgkin Study Group (GHSG) | Gleueler Str. 269-273 | 50937 Cologne
 
 Tel. +49 (0)221-478 5933
Fax +49 (0)221-478 3778
 
 E-Mail: info@hodgkinsymposium.org 
 For more information please click here.